On Tuesday, Thermo Fisher Scientific Inc. (NYSE: TMO) was -0.86% drop from the session before settling in for the closing price of $552.54. A 52-week range for TMO has been $420.21 – $627.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 12.53% over the last five years. When this article was written, the company’s average yearly earnings per share was at 0.68%. With a float of $381.39 million, this company’s outstanding shares have now reached $386.65 million.
The firm has a total of 122000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 41.24%, operating margin of 16.92%, and the pretax margin is 16.13%.
Thermo Fisher Scientific Inc. (TMO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Thermo Fisher Scientific Inc. stocks. The insider ownership of Thermo Fisher Scientific Inc. is 0.16%, while institutional ownership is 90.73%. The most recent insider transaction that took place on Oct 29 ’24, was worth 5,506,211. Before that another transaction happened on Oct 25 ’24, when Company’s SVP and General Counsel sold 2,000 for $560.16, making the entire transaction worth $1,120,320. This insider now owns 12,736 shares in total.
Thermo Fisher Scientific Inc. (TMO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 0.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.37% during the next five years compared to 16.37% growth over the previous five years of trading.
Thermo Fisher Scientific Inc. (NYSE: TMO) Trading Performance Indicators
You can see what Thermo Fisher Scientific Inc. (TMO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.94. Likewise, its price to free cash flow for the trailing twelve months is 26.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 15.95, a number that is poised to hit 5.94 in the next quarter and is forecasted to reach 23.56 in one year’s time.
Technical Analysis of Thermo Fisher Scientific Inc. (TMO)
Analysing the last 5-days average volume posted by the [Thermo Fisher Scientific Inc., TMO], we can find that recorded value of 1.53 million was better than the volume posted last year of 1.47 million. As of the previous 9 days, the stock’s Stochastic %D was 2.11%. Additionally, its Average True Range was 11.20.
During the past 100 days, Thermo Fisher Scientific Inc.’s (TMO) raw stochastic average was set at 19.50%, which indicates a significant increase from 0.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.49% in the past 14 days, which was lower than the 20.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $602.70, while its 200-day Moving Average is $578.62. Now, the first resistance to watch is $551.84. This is followed by the second major resistance level at $555.90. The third major resistance level sits at $558.20. If the price goes on to break the first support level at $545.48, it is likely to go to the next support level at $543.18. Should the price break the second support level, the third support level stands at $539.12.
Thermo Fisher Scientific Inc. (NYSE: TMO) Key Stats
There are 381,996K outstanding shares of the company, which has a market capitalization of 209.25 billion. As of now, sales total 42,857 M while income totals 5,995 M. Its latest quarter income was 10,598 M while its last quarter net income were 1,629 M.
